INVESTIGATION ALPHA-FETOPROTEIN IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA

Võ Duy Thông, Mai Hoài Sang

Main Article Content

Abstract

Objective: To investigate alpha-fetoprotein (AFP) level in cirrhotic patients with and without hepatocellular carcinoma (HCC). Method: A cross-sectional study describing 75 cases of patients with cirrhosis was conducted at the University Medical Center. We recorded 46 cases of HCC and 29 cases without HCC from September 2020 to January 2021. Results: The mean age of patients was 61,9 ± 10,9, the ratio male/female was 1,68/1. The AUROC of AFP levels for the diagnosis of HCC in cirrhotic patients was 0,8291 (p <0.05), AFP cut-off threshold ≥ 10,9 ng / ml was highest for diagnosing HCC in cirrhotic patients with the sensitivity of 80,43% and the specificity 75,86%. Conclusion: Serum AFP level is a simple test of high sensitivity and specificity in screening for HCC complications in cirrhotic patients.

Article Details

References

1. Hà Văn Mạo, Hoàng Kỷ, Phạm Hoàng Việt. Xơ gan và ung thư gan nguyên phát. Nhà xuất bản y học. 2006, 42-48
2. Coskun M. Hepatocellular Carcinoma in the Cirrhotic Liver: Evaluation Using Computed Tomography and Magnetic Resonance Imaging. Exp Clin Transplant 2017,15(2):99-107
3. Nguyễn Quang Tuấn, Nguyễn Sào Trung, Nguyễn Văn Thắng, Trần Minh Thôn. Ung thư gan nguyên phát: Đặc điểm giải phẫu bệnh - Lâm sàng. Tạp chí y học thành phố Hồ Chí Minh 2005. 9(1): 65-70
4. Vũ Văn Vũ, Võ Thị Xuân Hạnh, Mai Thị Bích Ngọc, Lê Ngọc Lan Thanh. Dịch tễ học, lâm sàng và cận lâm sàng ung thư gan nguyên phát - Khảo sát 107 trường hợp điều trị tại Bệnh viện Ung Bướu TPHCM 2009 -2010. Tạp chí y học thành phố Hồ Chí Minh 2010. 14 (4): 134-138.
5. Amoros R, King R, Toyoda H, Kumada T. A continuous-time hidden Markov model for cancer surveillance using serum biomarkers with application to hepatocellular carcinoma. Metron 2019. 77 (2): 87-94
6. Best J, Bilgi H, Heider D, Schotten C. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Z Gastroenterol 2016. 54 (12): 153-159.